Cancer affects us all. Millions of people around the world are living with the disease and every year, and millions more are newly diagnosed.
According to the National Cancer Institute, patients today usually receive the same treatment as others who have same type and stage of cancer despite growing evidence that they may respond differently.
Philips approach to precision medicine is to arm care teams with expert clinical guidance and a holistic view of the patient’s genotypic and phenotypic information in order to make decisions efficiently, collaboratively and accurately.
Recognizing the growing need for technological advancement in comprehensive oncology care (from early detection to diagnosis to treatment to survivorship), Philips vision to become an innovation leader in precision medicine with personalized patient/clinician-centered solutions that connect areas such as pathology, genomics, molecular/multi-disciplinary tumor boards, therapy decision making, molecular phenotyping, and more.
Our oncology and genomics solutions enable end-to-end oncology care. From molecular diagnostics to therapy options. We unify and streamline oncology care across the patient journey.
Philips Oncology Pathways Guide powered by Dana-Farber delivers expert, detailed, evidence-based treatment protocols. It can serve as an important tool in improving the quality of care and reducing costs. Based on the patient’s information, the clinician can make clinical decisions and provide a treatment plan and/or clinical trial recommendation. These results are then integrated back into the EMR and our tumor board.
Philips Genomics Workspace is a cloud-based solution that brings patient genomic data with disease histology, clinical phenotype, treatment options, and clinical trials for a comprehensive biomarker-informed, diagnostic and therapeutic picture. These results are then integrated back into the EMR and our tumor board.
Philips Oncology Platform for Multidisciplinary Team Orchestration brings actionable clinical patient information together from different vendors and disparate data sources, including electronic medical records, lab systems, pathology, radiology, and genomics. This cloud-based solution enables a comprehensive view of the patient by offering the power to visualize/analyze data, review diagnostics and staging information, document decisions, and communicate across specialties.
Discover Philips new integrated solution dedicated to Lung Cancer. Helping you diagnose and manage CT lung screenings and incidental pulmonary findings, while fostering collaborative treatment decision making.
Philips Oncology Pathways Guide Powered by Dana-Farber’s world-class content
Treating cancer is increasingly difficult as new data sources have provided a set of ever more complex treatment options from new drugs to genomic data. Clinical decision support within Oncology from Dana-Farber Cancer Institute, in Boston, powers complex cancer care, by enabling more personalized care plans for patients, while taking into account the various treatment options available. Dana-Farber is sharing its clinical decision support logic with Philips to bring enhanced cancer care to the oncology community.
How Philips is disrupting healthcare – The Atlantic and AWS Re:think series
The series “Disrupting Within” tackles the question: How does a company make that quarter turn with technology to stay competitive? Watch our AWS sponsored video on not only how Philips has managed to disrupt healthcare, but how our Oncology Pathways Guide powered by Dana-Farber Cancer Institute manages to use innovative technology to bring patients to the center of their evidence-based care.
Our Genomics Workspace enables general hospitals, laboratories, and university medical centers to tap into the expertise and treatment guidance of one of the world’s foremost cancer centers. Philips connects oncologists and pathologists around the world to MD Anderson’s extensive Precision Oncology Decision Support (PODS) system of actionable clinical information and clinical trial matching.
Philips HealthSuite is an open platform of services, capabilities and tools designed to inspire and enable the development of next generation connected health and wellness innovations. HealthSuite is purpose-built for healthcare. The health-optimized infrastructure allows for seamless integration with existing health enterprise ecosystems. Learn more by watching our video.
Philips vision is to become a leader in innovating precision medicine solutions that connect areas such as pathology, genomics, and molecular phenotyping molecular for personalized therapy decision making.
To learn more about this platform, we connected with Louis Culot, General Manager, Oncology Informatics and Genomics, and Dr. Qi Wei, Genomic Subject Matter Expert.
Journal of Clinical Pathways spoke with Kenna Shaw, PhD, cancer genomics laboratory, MD Anderson, and Louis Culot, general manager, genomics and oncology informatics, Philips, to better understand the PODS system and how this collaboration will improve patient care worldwide.
Genomics Workspace current product name is Pathology Genomics Workspace and Oncology Genomics Workspace. The name of the product will change to Genomics Workspace with the release of ISPM V5.3, subject to regulatory approval.
IntelliSpace Precision Medicine is an information management software only. It does not have the ability to diagnose disease, prescribe treatment, monitor prognosis, alleviate disease, or any other tasks that are constitutive of the practice of medicine.
By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.